4.5 Article

DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo

Journal

JOURNAL OF CLINICAL LABORATORY ANALYSIS
Volume 36, Issue 5, Pages -

Publisher

WILEY
DOI: 10.1002/jcla.24398

Keywords

buccal swab; DNA based-tests; sickle cell anemia; umbilical cord blood; venous blood

Funding

  1. VLIR-UOS under the grant Initiatives Sud et projets TEAM

Ask authors/readers for more resources

This study aims to adapt DNA-based SCA tests for use in limited resource countries and evaluate their economic benefit. The results show that the DNA-based test using dried blood spots (DBS cards) is feasible, with good sample conservation and high sensitivity and precision. Additionally, the cost of this approach is lower compared to the widely used isoelectric focusing of hemoglobin.
Background Hemoglobin-based tests form the reference diagnostic test for SCA. In limited resource countries, these tests face limitations including cost, low sensitivity due to recurrent transfusions in endemic malaria region, and interference from fetal hemoglobin in neonatal diagnostic. This study aimed at adapting DNA-based SCA tests to limited resource countries and evaluating the economic benefit. Methods 338 participants were recruited in the Democratic Republic of Congo, sorted in 3 cohorts based on venous blood, umbilical cord blood (UCB) and buccal swab sampling. RFLP was performed to identify mutated allele. The feasibility and technical validity of this RFLP was evaluated for specimens collected on DBS cards and on EDTA tubes. RFLP on DBS stored at room temperature was regularly repeated to assess sample conservation. Finally, the cost analysis was performed. Results DBS cards yielded identical results to extracted DNA. Repeated testing returned the same result after four years. The DBS-based test performed on UCB or on buccal swab had a sensitivity and a precision of 100%. Cost comparison indicated that our approach costs half price of the widely used isoelectrofocussing of hemoglobin. Conclusion The implemented DNA-based test approach overcomes the limitations faced by hemoglobin-based tests, while being more affordable. We propose to implement the RFLP test as a first line diagnostic test after transfusion and as second tiers for newborn screening. However, users should be aware that this test is unable to differentiate HbC from HbS or identify other point mutation of gene deletion of HBB gene.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available